Results
|
|
101.
|
|
|
|
102.
|
|
|
|
103.
|
|
|
|
104.
|
|
|
|
105.
|
|
|
|
106.
|
Kinetic Resolution of Amines by a Nonenzymatic Acylation Catalyst We thank Michael M.-C. Lo, Dr. J. Craig Ruble, and Beata Tao for helpful discussions and preliminary studies, and we also thank Dr. George P. Luke (ARIAD Pharmaceuticals, Inc.) for providing the primary amine illustrated in entry 8 of Table 1. Support has been provided by Bristol-Myers Squibb, Merck, the National Institutes of Health (National Institute of General Medical Sciences, R01-GM57034), Novartis, Pfizer, and Pharmacia. [electronic resource] by
Publication details: Angewandte Chemie (International ed. in English) Jan 2001
In:
Angewandte Chemie (International ed. in English) vol. 40
Availability: No items available.
|
|
|
107.
|
|
|
|
108.
|
|
|
|
109.
|
|
|
|
110.
|
|
|
|
111.
|
Kinetic Resolution of Amines by a Nonenzymatic Acylation Catalyst We thank Michael M.-C. Lo, Dr. J. Craig Ruble, and Beata Tao for helpful discussions and preliminary studies, and we also thank Dr. George P. Luke (ARIAD Pharmaceuticals, Inc.) for providing the primary amine illustrated in entry 8 of Table 1. Support has been provided by Bristol-Myers Squibb, Merck, the National Institutes of Health (National Institute of General Medical Sciences, R01-GM57034), Novartis, Pfizer, and Pharmacia. [electronic resource] by
Publication details: Angewandte Chemie (International ed. in English) Feb 2001
In:
Angewandte Chemie (International ed. in English) vol. 40
Availability: No items available.
|
|
|
112.
|
|
|
|
113.
|
|
|
|
114.
|
|
|
|
115.
|
|
|
|
116.
|
|
|
|
117.
|
|
|
|
118.
|
|
|
|
119.
|
|
|
|
120.
|
|